TORONTO, ONTARIO – December 4, 2020 – OB Pharmaceuticals, Inc., announced today the company will present its poster on its … Read More
LONDON, ONTARIO June 12, 2020 — OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski to Chief Scientific Advisor and … Read More
LONDON, ONTARIO June 12, 2020 — OB Pharmaceuticals has been granted patent US 10,618,870 from the U.S. Patent and Trademark … Read More
LONDON, ONTARIO June 12, 2020 — Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the Biotechnology Innovation Organization’s International Convention … Read More
LONDON, ONTARIO February 25, 2020 — OB Pharmaceuticals announces the addition of two new members to its Scientific and Clinical … Read More
LONDON, ONTARIO October 10, 2019 — Dr. Larry Mahan attended the Park City Epilepsy Conference held in Park City, UT … Read More
LONDON, ONTARIO August 20, 2019 — It is with great sadness that OB Pharmaceutical announces the sudden death of its … Read More
LONDON, ONTARIO May 16, 2019 — OB Pharmaceuticals CSO, Dr. Michael Poulter in the News. Dr. Michael Poulter, CSO was … Read More
LONDON, ONTARIO April 2, 2018 — Chairman and CEO John Poulter announced the appointment of Dr. Larry Mahan as the … Read More
LONDON, ONTARIO January 12, 2019 — Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the JP Morgan Healthcare Conference week … Read More